← Back to Screener
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP)
Price$320.13
Favorite Metrics
Price vs S&P 500 (26W)6.55%
Price vs S&P 500 (4W)9.76%
Market Capitalization$6.23B
Indicated Dividend Yield (Annual)0.49%
All Metrics
P/CF (Annual)46.37x
Book Value / Share (Quarterly)$16.15
P/TBV (Annual)4.60x
Indicated Dividend (Annual)$0.20
Revenue Growth (3Y)10.74%
Cash Flow / Share (Quarterly)$0.09
Payout Ratio (TTM)64.51%
Price vs S&P 500 (YTD)-16.69%
Gross Margin (TTM)47.13%
Net Profit Margin (TTM)-0.25%
EPS (TTM)$-0.06
10-Day Avg Trading Volume1.86M
EPS Excl Extra (TTM)$-0.06
Revenue Growth (5Y)11.57%
EPS (Annual)$-0.06
Dividend / Share (Annual)$0.22
ROI (Annual)-0.20%
Gross Margin (Annual)47.13%
Net Profit Margin (5Y Avg)8.14%
Cash / Share (Quarterly)$1.96
Revenue Growth QoQ (YoY)-0.24%
ROA (Last FY)-0.14%
Revenue Growth TTM (YoY)2.08%
EBITD / Share (TTM)$1.79
ROE (5Y Avg)17.91%
Operating Margin (TTM)1.40%
Cash Flow / Share (Annual)$0.09
P/B Ratio2.54x
P/B Ratio (Quarterly)2.91x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.27x
Net Interest Coverage (TTM)1.75x
ROA (TTM)-0.14%
EPS Growth QoQ (YoY)89.47%
EV / EBITDA (TTM)28.74x
EPS Incl Extra (Annual)$-0.06
Current Ratio (Annual)1.73x
Quick Ratio (Quarterly)0.83x
3-Month Avg Trading Volume2.24M
52-Week Price Return13.29%
EV / Free Cash Flow (Annual)549.50x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$10.23
P/S Ratio (Annual)1.81x
Asset Turnover (Annual)0.55x
52-Week High$56.22
Operating Margin (5Y Avg)12.22%
EPS Excl Extra (Annual)$-0.06
CapEx CAGR (5Y)4.34%
Tangible BV CAGR (5Y)16.29%
26-Week Price Return13.44%
Quick Ratio (Annual)0.83x
13-Week Price Return-16.90%
Total Debt / Equity (Annual)0.76x
Current Ratio (Quarterly)1.73x
Enterprise Value$7,802.918
Revenue / Share Growth (5Y)11.98%
Asset Turnover (TTM)0.55x
Book Value / Share Growth (5Y)20.62%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.64x
Pretax Margin (Annual)0.64%
Cash / Share (Annual)$1.96
3-Month Return Std Dev47.38%
Gross Margin (5Y Avg)49.86%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)-3.56%
EBITDA Interim CAGR (5Y)-0.38%
ROE (Last FY)-0.35%
Net Interest Coverage (Annual)1.75x
EPS Basic Excl Extra (Annual)$-0.06
P/FCF (TTM)28.71x
Receivables Turnover (TTM)5.22x
EV / Free Cash Flow (TTM)549.50x
Total Debt / Equity (Quarterly)0.76x
EPS Incl Extra (TTM)$-0.06
Receivables Turnover (Annual)5.22x
ROI (TTM)-0.20%
Dividend Growth Rate (5Y)6.15%
P/S Ratio (TTM)1.81x
Pretax Margin (5Y Avg)11.56%
Revenue / Share (Annual)$22.64
Tangible BV / Share (Annual)$10.23
Forward P/E19.44x
Free OCF CAGR (5Y)-42.95%
Price vs S&P 500 (52W)-21.35%
Year-to-Date Return-12.76%
5-Day Price Return3.01%
EPS Normalized (Annual)$-0.06
ROA (5Y Avg)5.53%
Net Profit Margin (Annual)-0.25%
Month-to-Date Return13.79%
Cash Flow / Share (TTM)$2.86
EBITD / Share (Annual)$1.79
Operating Margin (Annual)1.40%
LT Debt / Equity (Annual)0.75x
P/CF (TTM)46.37x
ROI (5Y Avg)8.60%
LT Debt / Equity (Quarterly)0.75x
EPS Basic Excl Extra (TTM)$-0.06
P/TBV (Quarterly)4.60x
Payout Ratio (Annual)26.70%
P/B Ratio (Annual)2.91x
Dividend / Share (TTM)$0.22
Inventory Turnover (TTM)1.64x
Pretax Margin (TTM)0.64%
Book Value / Share (Annual)$16.15
Price vs S&P 500 (13W)-19.28%
Dividend Yield (TTM)0.53%
Beta1.22x
P/FCF (Annual)438.92x
Revenue / Share (TTM)$22.59
ROE (TTM)-0.40%
52-Week Low$28.53
Industry Peers — Lab Analytical Instruments(22)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A | 1.81x | 11.57% | 47.13% | 1.40% | $320.13 |
AAgilent Technologies Inc. | 4.83x | 5.41% | 52.60% | 20.40% | $120.96 |
WATWaters Corp | 10.18x | 6.00% | 59.28% | 25.36% | $335.61 |
MTDMettler-Toledo International | 6.66x | 5.47% | 59.37% | 26.05% | $1324.66 |
ILMNIllumina Inc | 4.69x | 6.04% | 66.61% | 18.44% | $132.86 |
RVTYRevvity, Inc. | 3.64x | -5.46% | 54.77% | 12.49% | $93.03 |
BIOBio-Rad Laboratories, Inc.Class A | 3.17x | 0.29% | 52.01% | 1.59% | $303.34 |
BIO.BBio-Rad Laboratories, Inc. Class B | 3.17x | 0.29% | 52.01% | 1.59% | $277.00 |
BRKRBruker Corporation | 1.81x | 11.57% | 47.13% | 1.40% | $41.10 |
AVTRAvantor, Inc. | 0.88x | 0.49% | 32.65% | -3.83% | $8.50 |
TXG10x Genomics, Inc. Class A Common Stock | 5.18x | 16.56% | 69.13% | -9.49% | $24.59 |
About
Bruker Corp manufactures scientific instruments and diagnostic tests for the life sciences, pharmaceutical, and biotechnology industries across four segments: BioSpin, CALID, Nano, and Supercon Technologies. CALID is the primary revenue driver, with the United States as the largest geographic market.